Search by Drug Name or NDC

    NDC 69097-0880-67 Lanreotide Acetate 60 mg/.2mL Details

    Lanreotide Acetate 60 mg/.2mL

    Lanreotide Acetate is a SUBCUTANEOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cipla USA Inc.. The primary component is LANREOTIDE ACETATE.

    Product Information

    NDC 69097-0880
    Product ID 69097-880_9f320a1b-c81d-43e7-8add-3934ff3c7394
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Lanreotide Acetate
    Proprietary Name Suffix n/a
    Non-Proprietary Name lanreotide acetate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 60
    Active Ingredient Units mg/.2mL
    Substance Name LANREOTIDE ACETATE
    Labeler Name Cipla USA Inc.
    Pharmaceutical Class Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA215395
    Listing Certified Through 2024-12-31

    Package

    NDC 69097-0880-67 (69097088067)

    NDC Package Code 69097-880-67
    Billing NDC 69097088067
    Package 1 SYRINGE in 1 CARTON (69097-880-67) / .2 mL in 1 SYRINGE
    Marketing Start Date 2021-12-24
    NDC Exclude Flag N
    Pricing Information N/A